Prognostic Significance of Fibrotic Focus and Tumor Infiltrating Lymphocytes in Breast Cancer According to Molecular Subtypes

키워드

참고문헌 (30)

1. Osipov A, "From immune checkpoints to vaccines : the past, present and future of cancer immunotherapy", Adv Cancer Res, 143, pp.63~144 (2019)
2. Balkwill F, "The tumor microenvironment at a glance", J Cell Sci, 125, pp.5591~5596 (2012)
3. Baghban R, "Tumor microenvironment complexity and therapeutic implications at a glance", Cell Commun Signal, 18, pp.59~ (2020)
4. Wang M, "Role of tumor microenvironment in tumorigenesis", J Cancer, 8, pp.761~773 (2017)
5. Bejarano L, "Therapeutic targeting of the tumor microenvironment", Cancer Discov, 11, pp.933~959 (2021)
6. Chandler C, "The double edge sword of fibrosis in cancer", Transl Res, 209, pp.55~67 (2019)
7. Boulter L, "The fibrotic and immune microenvironments as targetable drivers of metastasis", Br J Cancer, 124, pp.27~36 (2021)
8. Bozóky B, "Novel signatures of cancer-associated fibroblasts", Int J Cancer, 133, pp.286~293 (2013)
9. LeBleu VS, "A peek into cancer-associated fibroblasts: origins, functions and translational impact", Dis Model Mech, 11, pp.dmm029447~ (2018)
10. Han W, "Oriented collagen fibers direct tumor cell intravasation", Proc Natl Acad Sci USA, 113, pp.11208~11213 (2016)
11. Fang M, "Collagen as a double-edged sword in tumor progression", Tumour Biol, 35, pp.2871~2882 (2014)
12. Lin B, "Tumor-infiltrating lymphocytes : warriors fight against tumors powerfully", Biomed Pharmacother, 132, pp.110873~ (2020)
13. Basu A, "Immunotherapy in breast cancer : current status and future directions", Adv Cancer Res, 143, pp.295~349 (2019)
14. Salgado R, "The evaluation of tumor-infiltrating lymphocytes(TILs)in breast cancer : recommendations by an International TILs Working Group 2014", Ann Oncol, 26, pp.259~271 (2015)
15. Denkert C, "Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer : a pooled analysis of 3771 patients treated with neoadjuvant therapy", Lancet Oncol, 19, pp.40~50 (2018)
16. Gao ZH, "Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes : a meta-analysis", BMC Cancer, 25(20), pp.1150~ (2020)
17. Dieci MV, "Update on tumor-infiltrating lymphocytes(TILs)in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ : a report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer", Semin Cancer Biol, 52, pp.16~25 (2018)
18. Hasebe T, "Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast : a prospective observational study", Mod Pathol, 15, pp.502~516 (2002)
19. Wolff AC, "Human epidermal growth factor receptor 2 testing in breast cancer : American Society of Clinical Oncology", College of American Pathologists clinical practice guideline focused update, 2018, pp.142, 1364~1382
20. Van den Eynden GG, "A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and(lymph)angiogenesis in breast cancer : review of the literature and proposal on the criteria of evaluation", Histopathology, 51, pp.440~451 (2007)
21. 정영주, "Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal Carcinoma In Situ and Invasive Breast Cancer", Journal of Breast Cancer, 14(2), pp.96~103 (2011), 한국유방암학회
22. Mujtaba SS, "Fibrotic focus in breast carcinomas : relationship with prognostic parameters and biomarkers", Ann Surg Oncol, 20, pp.2842~2849 (2013)
23. Yanai H, "Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer : results from a retrospective single-center study", PLoS One, 16, pp.e0245725~ (2021)
24. Shimada H, "Fibrotic focus : an important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast", Pathol Int, 67, pp.331~341 (2017)
25. Loi S, "Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy : BIG 02-98", J Clin Oncol, 31, pp.860~867 (2013)
26. Loi S, "Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer : results from the FinHER trial", Ann Oncol, 25, pp.1544~1550 (2014)
27. Adams S, "Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials : ECOG 2197 and ECOG 1199", J Clin Oncol, 32, pp.2959~2966 (2014)
28. He L, "Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes : a meta-analysis", BMC Women Health, 20, pp.94~ (2020)
29. Hasebe T, "Fibrotic focus in infiltrating ductal carcinoma of the breast : a significant histopathological prognostic parameter for predicting the long-term survival of the patients", Breast Cancer Res Treat, 49, pp.195~208 (1998)
30. Li Y, "Association between the degree of fibrosis in fibrotic focus and the unfavorable clinicopathological prognostic features of breast cancer", PeerJ, 7, pp.e8067~ (2019)

관련 논문AI추천